Biogen Inc.

BIIB Stock Healthcare Drug Manufacturers - General
$218.50
-3.00 (-1.35%)
Price as of Aug 28, 2026 market close

Performance

1 Month
+5.1%
3 Months
+11.5%
YTD
+24.2%
1 Year
+60.2%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
35.5%
Largest decline max drawdown, since Aug 2025
-14.3%
Risk-adjusted return Sharpe ratio, 1-year
1.51

Own BIIB?

See how BIIB contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.